PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.78%
Revenue growth 1.25-1.5x MRVL's 4.29%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
1.19%
Gross profit growth under 50% of MRVL's 3.82%. Michael Burry would be concerned about a severe competitive disadvantage.
8.44%
EBIT growth similar to MRVL's 8.09%. Walter Schloss might infer both firms share similar operational efficiencies.
8.44%
Operating income growth at 50-75% of MRVL's 15.99%. Martin Whitman would doubt the firm’s ability to compete efficiently.
3.96%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
5.56%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
5.56%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.59%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.84%
Diluted share count expanding well above MRVL's 1.17%. Michael Burry would fear significant dilution to existing owners' stakes.
38.32%
Maintaining or increasing dividends while MRVL cut them. John Neff might see a strong edge in shareholder returns.
30.10%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
26.88%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
129.53%
10Y revenue/share CAGR above 1.5x MRVL's 56.20%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
77.01%
5Y revenue/share CAGR at 50-75% of MRVL's 109.65%. Martin Whitman would worry about a lagging mid-term growth trajectory.
44.21%
3Y revenue/share CAGR above 1.5x MRVL's 25.49%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
2867.62%
5Y OCF/share CAGR above 1.5x MRVL's 45.44%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
31.90%
3Y OCF/share CAGR at 50-75% of MRVL's 63.72%. Martin Whitman would suspect weaker recent execution or product competitiveness.
378.63%
Net income/share CAGR at 50-75% of MRVL's 653.69%. Martin Whitman might question if the firm’s product or cost base lags behind.
3684.73%
5Y net income/share CAGR above 1.5x MRVL's 220.76%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
303.89%
3Y net income/share CAGR 1.25-1.5x MRVL's 202.86%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
37.08%
5Y equity/share CAGR above 1.5x MRVL's 19.67%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
53.77%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
20.80%
Stable or rising mid-term dividends while MRVL is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
10.83%
Our short-term dividend growth is positive while MRVL cut theirs. John Neff views it as a comparative advantage in shareholder returns.
13.60%
AR growth well above MRVL's 11.24%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.04%
Inventory growth well above MRVL's 4.05%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.58%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
7.55%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
4.60%
Debt growth far above MRVL's 3.89%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
2.79%
R&D growth drastically higher vs. MRVL's 1.74%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-5.72%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.